ALT - Altimmune, Inc.
2.6
-0.030 -1.154%
Share volume: 5,638,491
Last Updated: 04-30-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$2.63
-0.03
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-13-2025 | 08-12-2025 | 11-06-2025 | 03-06-2026 | |
| Assets | |||||||||
| Total Assets | 188.358 M | 173.346 M | 147.864 M | 139.306 M | 157.263 M | 190.350 M | 218.447 M | 279.929 M | |
| Current Assets | 187.515 M | 171.186 M | 145.759 M | 137.254 M | 155.262 M | 188.422 M | 216.615 M | 278.192 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.272 M | 2.588 M | 2.912 M | 2.573 M | 1.957 M | 557.000 K | 547.000 K | 518.000 K | |
| Short Term Investments | 103.046 M | 107.780 M | 107.906 M | 94.965 M | 100.722 M | 0.000 | 149.540 M | 229.696 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 78.978 M | 57.128 M | 31.474 M | 36.926 M | 49.104 M | 183.105 M | 61.236 M | 43.760 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 544.000 K | 483.000 K | 446.000 K | 413.000 K | 384.000 K | 364.000 K | 337.000 K | 312.000 K | |
| Other Assets | 299.000 K | 1.677 M | 1.659 M | 1.639 M | 1.617 M | 1.564 M | 1.495 M | 1.425 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 188.358 M | 173.346 M | 147.864 M | 139.306 M | 157.263 M | 190.350 M | 218.447 M | 279.929 M | |
| Total liabilities | 15.421 M | 20.815 M | 14.487 M | 15.798 M | 15.101 M | 28.983 M | 32.846 M | 55.037 M | |
| Total current liabilities | 11.333 M | 15.155 M | 8.638 M | 10.468 M | 9.798 M | 9.220 M | 12.606 M | 14.997 M | |
| Accounts Payable | 3.760 M | 2.688 M | 1.133 M | 211.000 K | 1.077 M | 851.000 K | 4.804 M | 2.717 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 5.431 M | 5.795 M | 5.753 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 14.332 M | 14.445 M | 34.287 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 5.431 M | 5.795 M | 5.753 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 172.937 M | 152.531 M | 133.377 M | 123.508 M | 142.162 M | 161.367 M | 185.601 M | 224.892 M | |
| Common stock | 668.823 M | 673.088 M | 676.432 M | 689.871 M | 728.130 M | 769.517 M | 812.742 M | 879.303 M | |
| Retained earnings | -490.725 M | -515.365 M | -538.210 M | -561.390 M | -580.965 M | -603.111 M | -622.125 M | -649.483 M |